| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.51 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |